{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-25-000792","form_type":"8-K","ticker":"VANI","cik":"0001266806","company_name":"Vivani Medical, Inc.","filed_at":"2025-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.801264+00:00","generated_at":"2026-05-21T13:20:04.451876+00:00","sec_items":["1.01","2.02","3.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Vivani Medical Q1 net loss $6.3M; secures $3M private placement; LIBERATE-1 data mid-2025","bullets":["Q1 net loss of $6.3M (vs $6.0M prior year); cash, equivalents & restricted cash $14.3M as of March 31.","Announced $3.0M private placement with Chairman Gregg Williams entity at $1.03/share (2.9M shares).","LIBERATE-1 Phase 1 study on track; all NPM-115 (exenatide) implant insertions successful; top-line results mid-2025.","Promising preclinical data for NPM-139 semaglutide implant for chronic weight management in obese/overweight.","Plans to spin off Cortigent brain implant division as an independent publicly traded company."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-25-000792","json":"https://secwatch.observer/filing/0001753926-25-000792.json","markdown":"https://secwatch.observer/filing/0001753926-25-000792.md","text":"https://secwatch.observer/filing/0001753926-25-000792.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1266806/000175392625000792/0001753926-25-000792-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1266806/000175392625000792/vani-20250512.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T13:20:04.451876+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}